Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chizuru Arisawa is active.

Publication


Featured researches published by Chizuru Arisawa.


International Journal of Urology | 2006

Successful management of vesicouterine fistula by luteinizing hormone‐releasing hormone analog

Minato Yokoyama; Chizuru Arisawa; Masao Ando

Abstract  Vesicouterine fistula is a rare complication of cesarean section. Although surgical repair was mandatory for the management of the fistula previously, a recent review showed high efficacy of hormonal manipulation by the induction of amenorrhea. Herein, we report a new case of vesicouterine fistula secondary to cesarean section successfully treated by luteinizing hormone‐releasing hormone analog for 6 months. Conservative hormonal treatment for vesicouterine fistula caused by cesarean section should be considered before surgical repair.


International Journal of Urology | 2001

Appendiceal carcinoma invading the urinary bladder

Chizuru Arisawa; Sin-Ichi Takeuchi; Mamoru Wakui

Abstract A case is reported of a 78‐year‐old woman with appendiceal carcinoma invading the bladder causing irritative symptoms. Although several imaging studies suggested that the secondary bladder tumor was of cecal or appendiceal origin, such as abscess or mucocele, histologic findings on transurethral and transvaginal biopsy were inconclusive. However, following laparotomy, pathologic examination of the frozen sections revealed a mucinous cystadenocarcinoma originating in the appendix and a right hemicolectomy and en bloc partial cystectomy were performed. One year after the operation, the patient was well with no evidence of recurrent cancer.


BJUI | 2015

Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy

Junichiro Ishioka; Kazutaka Saito; Toshiki Kijima; Yasukazu Nakanishi; Soichiro Yoshida; Minato Yokoyama; Yoh Matsuoka; Noboru Numao; Fumitaka Koga; Hitoshi Masuda; Yasuhisa Fujii; Yasuyuki Sakai; Chizuru Arisawa; Tetsuo Okuno; Katsuhi Nagahama; Shigeyoshi Kamata; Mizuaki Sakura; Junji Yonese; Shinji Morimoto; Akira Noro; Toshihiko Tsujii; Satoshi Kitahara; Shuichi Gotoh; Yotsuo Higashi; Kazunori Kihara

To identify risk factors and develop a model for predicting recurrence of upper urinary tract urothelial carcinoma (UTUC) in the bladder in patients without a history of bladder cancer after radical nephroureterectomy (RNU).


Urology | 2011

Young Age as Favorable Prognostic Factor for Cancer-specific Survival in Localized Renal Cell Carcinoma

Yoshinobu Komai; Yasuhisa Fujii; Yasumasa Iimura; Manabu Tatokoro; Kazutaka Saito; Yukihiro Otsuka; Fumitaka Koga; Chizuru Arisawa; Satoru Kawakami; Tetsuo Okuno; Toshihiko Tsujii; Yukio Kageyama; Shinji Morimoto; Tsuguhiro Toma; Yotsuo Higashi; Iwao Fukui; Kazunori Kihara

OBJECTIVES To evaluate the prognostic effect of age in patients with localized renal cell carcinoma (RCC) and investigate the incidence of Xp11 translocation RCC in young patients who developed recurrence. METHODS From 1990 to 2007, 2403 Japanese patients underwent nephrectomy for presumed RCC at 9 institutions. Of those, 1143 patients had localized RCC (Stage pT1-2N0M0). Their clinical data were retrospectively reviewed. In the present study, 131 patients (11%) were considered young (≤45 years at diagnosis). In the young patients with recurrence, the nephrectomy specimens were immunostained with TFE3 to determine the incidence of Xp11 translocation RCC. RESULTS During the median follow-up of 47 months, 3 cancer deaths (2.2%) occurred among young patients and 51 (5.0%) among older patients. The 5-year cancer-specific survival (CSS) rate was significantly better for the younger patients than for the older patients (P = .049). Multivariate analysis showed that age was significantly associated with CSS, as were the pathologic T stage, tumor grade, and symptoms at diagnosis. The hazard ratio of young age was 0.31 (95% confidence interval 0.077-0.87). The recurrence-free survival curves revealed no difference between these 2 groups. Of the 74 patients with recurrence, the CSS after recurrence was significantly better in the younger patients than in the older patients (P = .0010). Of the 8 young patients with recurrence, 4 had Xp11 translocation RCC, and 3 survived for >5 years after recurrence. CONCLUSIONS Compared with the older patients, the young patients with RCC had similar recurrence-free survival rates but better CSS rates. This might have been because significant numbers of the young patients had Xp11 translocation RCC.


International Journal of Urology | 2014

Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: A propensity score-matched multicenter study

Hiroshi Fukushima; Kazutaka Saito; Junichiro Ishioka; Yoh Matsuoka; Noboru Numao; Fumitaka Koga; Hitoshi Masuda; Yasuhisa Fujii; Yasuyuki Sakai; Chizuru Arisawa; Tetsuo Okuno; Junji Yonese; Shigeyoshi Kamata; Katsushi Nagahama; Akira Noro; Shinji Morimoto; Toshihiko Tsujii; Satoshi Kitahara; Shuichi Gotoh; Yotsuo Higashi; Kazunori Kihara

To investigate the oncological and functional outcome of distal ureterectomy compared with nephroureterectomy in the management of distal ureteral urothelial carcinoma.


International Journal of Urology | 1999

Possible misinterpretation on computed tomography of left inferior vena cava as retroperitoneal lymph node metastasis:A report of two cases

Chizuru Arisawa; Kazunori Kihara; Yasuhisa Fujii; Kazuhiro Ishizaka; Hitoshi Masuda; Hiroyuki Oshima

Purpose: We report on two cases of retroperitoneal lymph node metastasis of testicular cancer with left inferior vena cava.


International Journal of Urology | 1999

Endocrinologically active retroperitoneal ganglioneuroma with positive iodine-131-metaiodobenzylguanidine scintigraphy

Akira Tosaka; Masao Ando; Chizuru Arisawa; Tadao Okano

Background : A case of retroperitoneal ganglioneuroma incidentally found by ultrasonography in a 56‐year old woman is presented.


International Journal of Urology | 1999

A case of perirenal hemangioma mimicking renal cell carcinoma

Tetsuo Okuno; Masao Ando; Chizuru Arisawa; Tadao Okano

Purpose: We present a rare case of perirenal hemangioma that was detected incidentally.


International Journal of Urology | 2014

Renal function after radical nephrectomy: development and validation of predictive models in Japanese patients.

Minato Yokoyama; Yasuhisa Fujii; Hideki Takeshita; Naoko Kawamura; Takayuki Nakayama; Yasumasa Iimura; Mizuaki Sakura; Junichiro Ishioka; Kazutaka Saito; Fumitaka Koga; Hitoshi Masuda; Akira Noro; Chizuru Arisawa; Satoshi Kitahara; Kazunori Kihara

To develop and validate predictive models for postoperative estimated glomerular filtration rate and risk of chronic kidney disease after radical nephrectomy in Japanese patients.


International Journal of Urology | 2003

Successful long-term disease-free survival following multimodal treatments in a patient with a repeatedly recurrent refractory adrenal cortical carcinoma.

Yasuhisa Fujii; Yukio Kageyama; Satoru Kawakami; Hitoshi Masuda; Chizuru Arisawa; Hideki Akamatsu; Takumi Akashi; Kazunori Kihara

Abstract A 47‐year‐old male patient underwent surgery for a 10‐cm adrenal cortical carcinoma. A large invasive adrenal mass was surgically removed en bloc with the right kidney and the lower lobe of the liver. Two months postoperatively, a 7‐cm recurrent mass developed in the right psoas muscle. After a partial response was achieved by irradiation (40 Gy) and high‐dose chemotherapy (carboplatin and etoposide) with peripheral blood stem cell transplantation, the patient underwent surgery with a wide excision of the psoas muscle. Twelve months after the initial surgery, an 8‐cm rib metastasis developed and the patient again underwent surgery after a combination of irradiation (50 Gy) and chemotherapy (cisplatin and etoposide). The patient has been doing well without any evidence of recurrence for 5 years. Refractory or metastatic adrenal cortical carcinomas have been thought to be lethal, therefore, the present case provides support for multimodal treatments of refractory adrenocortical cancers.

Collaboration


Dive into the Chizuru Arisawa's collaboration.

Top Co-Authors

Avatar

Kazunori Kihara

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Yasuhisa Fujii

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Kazutaka Saito

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Shinji Morimoto

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Tetsuo Okuno

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Noboru Numao

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Fumitaka Koga

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Junichiro Ishioka

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Yoh Matsuoka

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Junji Yonese

Japanese Foundation for Cancer Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge